SCHEMBL19207819

SCHEMBL19207819

O=C(O)NC1CCc2ccccc2-n2ccnc21

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26167133 0.88 RIPK1 (0.62) RIPK1
SCHEMBL1976325 0.83 RIPK1 (0.57) RIPK1
SCHEMBL1976019 0.83 RIPK1 (0.57) RIPK1
SCHEMBL1975216 0.83 RIPK1 (0.60) RIPK1
SCHEMBL19224518 0.83 RIPK1 (0.60) RIPK1
SCHEMBL1976517 0.83 RIPK1 (0.60) RIPK1
SCHEMBL30374548 0.83 RIPK1 (0.60) RIPK1
SCHEMBL1979882 0.81 RIPK1 (0.55) RIPK1
SCHEMBL26240321 0.81 RIPK1 (0.54) RIPK1
SCHEMBL19207671 0.81 RIPK1 (0.64) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed